Hill SM - Search Results

1

Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesis.

Blask DE, Hill SM, Orstead KM, Massa JS. Blask DE, et al. Among authors: hill sm. J Neural Transm. 1986;67(1-2):125-38. doi: 10.1007/BF01243365. J Neural Transm. 1986. PMID: 3097252

2

Melatonin decreases estrogen receptor expression in the medial preoptic area of inbred (LSH/SsLak) golden hamsters.

Lawson NO, Wee BE, Blask DE, Castles CG, Spriggs LL, Hill SM. Lawson NO, et al. Among authors: hill sm. Biol Reprod. 1992 Dec;47(6):1082-90. doi: 10.1095/biolreprod47.6.1082. Biol Reprod. 1992. PMID: 1493172

3

The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.

Hill SM, Spriggs LL, Simon MA, Muraoka H, Blask DE. Hill SM, et al. Cancer Lett. 1992 Jul 10;64(3):249-56. doi: 10.1016/0304-3835(92)90050-6. Cancer Lett. 1992. PMID: 1638517

4

Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo.

Blask DE, Pelletier DB, Hill SM, Lemus-Wilson A, Grosso DS, Wilson ST, Wise ME. Blask DE, et al. Among authors: hill sm. J Cancer Res Clin Oncol. 1991;117(6):526-32. doi: 10.1007/BF01613283. J Cancer Res Clin Oncol. 1991. PMID: 1744157

5

Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.

Hill SM, Blask DE. Hill SM, et al. Cancer Res. 1988 Nov 1;48(21):6121-6. Cancer Res. 1988. PMID: 3167858

6

Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture.

Blask DE, Hill SM. Blask DE, et al. Among authors: hill sm. J Neural Transm Suppl. 1986;21:433-49. J Neural Transm Suppl. 1986. PMID: 3462341

7

Melatonin synergizes with retinoic acid in the prevention and regression of breast cancer.

Hill SM, Teplitzky S, Ram PT, Kiefer T, Blask DE, Spriggs LL, Eck KM. Hill SM, et al. Adv Exp Med Biol. 1999;460:345-62. doi: 10.1007/0-306-46814-x_39. Adv Exp Med Biol. 1999. PMID: 10810532 Review. No abstract available.

8

Melatonin and 9-cis-retinoic acid in the chemoprevention of NMU-induced rat mammary carcinoma.

Teplitzky SR, Blask DE, Cheng Q, Myers L, Hill SM. Teplitzky SR, et al. Among authors: hill sm. Adv Exp Med Biol. 1999;460:363-7. doi: 10.1007/0-306-46814-x_40. Adv Exp Med Biol. 1999. PMID: 10810533 No abstract available.

9

Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid.

Teplitzky SR, Kiefer TL, Cheng Q, Dwivedi PD, Moroz K, Myers L, Anderson MB, Collins A, Dai J, Yuan L, Spriggs LL, Blask DE, Hill SM. Teplitzky SR, et al. Among authors: hill sm. Cancer Lett. 2001 Jul 26;168(2):155-63. doi: 10.1016/s0304-3835(01)00548-1. Cancer Lett. 2001. PMID: 11403920

10

Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.

Hill SM, Cheng C, Yuan L, Mao L, Jockers R, Dauchy B, Frasch T, Blask DE. Hill SM, et al. Breast Cancer Res Treat. 2011 May;127(1):91-8. doi: 10.1007/s10549-010-0958-0. Epub 2010 Jun 12. Breast Cancer Res Treat. 2011. Retraction in: Breast Cancer Res Treat. 2024 Jul;206(1):211. doi: 10.1007/s10549-024-07330-w PMID: 20549340 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters